Orientbio, Inc.

Orientbio, Inc. financial statements

Orientbio, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2026

RevenueKRW 29.75BEODHD
Net income−KRW 4.57BEODHD
Cash and equivalentsKRW 5.83BEODHD

Orientbio, Inc. financials on 6ix · Orientbio, Inc. on 6ix